ZPHC Semaglutide (AQ Pen) 6 mg
ALSO KNOWN AS
- GLP-1 Pen
- Semaglutide Pen
- Weight Loss Peptide
DESCRIPTION
ZPHC Semaglutide (AQ Pen) 6 mg is a pre-mixed, ready-to-use injectable GLP-1 receptor agonist. It works by slowing gastric emptying, reducing appetite, and improving insulin sensitivity—making it ideal for fat loss and metabolic optimization research. The dial-a-dose pen format allows for micro-precision delivery without the need for mixing or syringes.
DOSAGE & ADMINISTRATION
- Total Concentration: 6 mg per pen
• Delivery Format: 24 clicks × 0.25 mg per click
• Suggested Research Titration:
– Start: 0.25 mg weekly
– Increase by 0.25 mg every 4 weeks
– Max: 1 mg per week, as tolerated
• Administration: Subcutaneous injection using dial-a-dose pen
CYCLE USE
Commonly used in long-term metabolic research, including studies on weight loss, blood sugar regulation, and appetite control. Can be combined with other metabolic agents for enhanced outcomes.
PACKAGE CONTENTS
1 pre-filled 6 mg aqueous pen (24 × 0.25 mg clicks)
STORAGE INSTRUCTIONS
- Refrigerate at 2–8°C after opening
- Stable for 28 days at 2–8°C
- Do not freeze
- Protect from light
